Kestra Private Wealth Services’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$393K Sell
3,077
-451
-13% -$56.3K ﹤0.01% 1320
2025
Q4
$430K Sell
3,528
-163
-4% -$18.7K 0.01% 1254
2025
Q3
$370K Sell
3,691
-143
-4% -$12.9K ﹤0.01% 1250
2025
Q2
$318K Sell
3,834
-13,637
-78% -$1.09M ﹤0.01% 1251
2025
Q1
$1.42M Sell
17,471
-614
-3% -$54.9K 0.02% 555
2024
Q4
$1.63M Sell
18,085
-600
-3% -$58.1K 0.03% 491
2024
Q3
$1.85M Sell
18,685
-97
-0.5% -$9.53K 0.03% 446
2024
Q2
$1.74M Sell
18,782
-700
-4% -$62.8K 0.03% 425
2024
Q1
$1.85M Buy
19,482
+475
+2% +$44.1K 0.04% 396
2023
Q4
$1.7M Buy
19,007
+14,453
+317% +$1.07M 0.04% 387
2023
Q3
$333K Buy
4,554
+574
+14% +$45.9K 0.01% 822
2023
Q2
$331K Buy
3,980
+260
+7% +$21.7K 0.01% 783
2023
Q1
$284K Buy
3,720
+108
+3% +$8.96K 0.01% 802
2022
Q4
$300K Sell
3,612
-466
-11% -$37.7K 0.02% 673
2022
Q3
$323K Buy
4,078
+333
+9% +$28.1K 0.02% 624
2022
Q2
$278K Sell
3,745
-758
-17% -$56.9K 0.02% 680
2022
Q1
$405K Buy
4,503
+1,822
+68% +$168K 0.02% 646
2021
Q4
$300K Buy
2,681
+261
+11% +$31.5K 0.01% 762
2021
Q3
$304K Sell
2,420
-4,250
-64% -$547K 0.02% 702
2021
Q2
$903K Sell
6,670
-8
-0.1% -$1.05K 0.05% 355
2021
Q1
$906K Sell
6,678
-634
-9% -$94.9K 0.06% 312
2020
Q4
$1.05M Sell
7,312
-1,149
-14% -$147K 0.08% 256
2020
Q3
$934K Buy
+8,461
New +$949K 0.08% 252

Other funds holding XBI

Kestra Private Wealth Services's XBI Position: Q1 2026 in Review

Kestra Private Wealth Services reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 13% in Q1 2026, selling an estimated $56.3K and leaving 3,077 shares worth $393K. The position accounts for ﹤0.01% of the portfolio, ranked #1320.

Kestra Private Wealth Services first reported a position in XBI in Q3 2020 and has held it in 23 quarters since. The position peaked at $1.85M in Q1 2024. 813 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

  • Kestra Private Wealth Services held 3,077 shares of State Street SPDR S&P Biotech ETF worth $393K as of Q1 2026.
  • Kestra Private Wealth Services sold 451 State Street SPDR S&P Biotech ETF shares in Q1 2026, an estimated $56.3K.
  • State Street SPDR S&P Biotech ETF made up ﹤0.01% of Kestra Private Wealth Services's portfolio in Q1 2026, its #1320 holding.
  • Kestra Private Wealth Services first reported a position in State Street SPDR S&P Biotech ETF in Q3 2020 and has held it in 23 quarters since.
  • Kestra Private Wealth Services's State Street SPDR S&P Biotech ETF position peaked at $1.85M in Q1 2024.
  • 813 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on Kestra Private Wealth Services's 13F filing for Q1 2026, filed 20 Apr 2026.